
DeLorean AI is a healthcare technology company specializing in predictive AI solutions. Their flagship product, MARTI Medical AI, aims to transform healthcare by predicting disease onset and progression, enabling proactive interventions. MARTI has achieved 85-87% prediction accuracy and has been biologically validated by independent third-party labs, a world first. The system is deployed across 14 clients, including a Fortune 5 healthcare organization, and models over 50 million patients. MARTI offers specialized modules for renal disease, diabetes, cardiovascular disease, behavioral health, and respiratory disease, with a business model of AI as a Service. The company's technology focuses on reducing Medical Loss Ratio (MLR) and increasing revenue by preventing disease progression, offering significant cost savings per patient for conditions like ESRD, CKD, Diabetes, and CVD. DeLorean AI's mission is to shift healthcare from a disease-profit model to a wellness-profit model, ensuring longer, healthier lives through predictive and personalized care.

DeLorean AI is a healthcare technology company specializing in predictive AI solutions. Their flagship product, MARTI Medical AI, aims to transform healthcare by predicting disease onset and progression, enabling proactive interventions. MARTI has achieved 85-87% prediction accuracy and has been biologically validated by independent third-party labs, a world first. The system is deployed across 14 clients, including a Fortune 5 healthcare organization, and models over 50 million patients. MARTI offers specialized modules for renal disease, diabetes, cardiovascular disease, behavioral health, and respiratory disease, with a business model of AI as a Service. The company's technology focuses on reducing Medical Loss Ratio (MLR) and increasing revenue by preventing disease progression, offering significant cost savings per patient for conditions like ESRD, CKD, Diabetes, and CVD. DeLorean AI's mission is to shift healthcare from a disease-profit model to a wellness-profit model, ensuring longer, healthier lives through predictive and personalized care.
Sector: Healthcare AI (Medical AI) with CRM AI products
Flagship product: MARTI (Medical Artificial Real Time Intelligence) — population-scale predictive models
Clients / scale: Deployed with 14 clients including a Fortune 5 healthcare organization; models >50M patients
Validation / accuracy: Reports biological validation and ~85–87% prediction accuracy
Funding: Series A announced Aug 1, 2023; total funding reported ~ $11M (Series A ~$7.55M)
Chronic disease prediction and care management for healthcare payers and providers; reducing costs and improving outcomes via predictive analytics.
Healthtech / Artificial Intelligence
7.55M USD
Reported Series A announced Aug 1, 2023; participating investors noted include Pinta Capital Partners.
“Led by Sopris Capital Associates with participation from Pinta Capital Partners”